Licensing Opportunity Available to Pharmaceutical Companies
Med Services Europe GmbH announced that it has obtained rights to out-license a portfolio of prescription pharmaceuticals.
Dr. Gene Emmer, President of Med Services Europe explained: "We have signed an agreement with a European-based pharmaceutical company that grants us the right to develop a network of distributors for an exciting portfolio of prescription pharmaceutical products. Our client will launch the portfolio in their home market. Med Services Europe will build and manage a network of pharmaceutical companies which will be responsible for marketing, sales and distribution of these products in their home markets. The products in the portfolio offer physicians options for handling Hormone Replacement Therapy (HRT)."
Dr Emmer encourages pharmaceutical companies to learn more about the opportunity to in-license this portfolio of products. "This is a unique opportunity to obtain marketing rights to an exciting portfolio of products, which are effective for a large and growing market. The media attention to WHI has served to decrease the competitive noise in this market and make this an exciting time for companies coming with a new message."
Organizations
Other news from the department research and development
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.